MSPRX Mutual Fund

MSPRX Mutual Fund

NAV$23.37
See how much of MSPRX you already own
Just $25 once·$69/mo·Download sample
X-ray my portfolio free

Fund Essentials - as of Dec 31, 2025

Net Assets
-
Expense Ratio
1.95%
Dividend Yield (Current)
-
Holdings
33
Inception Date
Apr 30, 2015
Fund Family
Morgan Stanley Investment Management
Investment Style
PRO
Asset Class
PRO
Legal Structure
PRO
Dividend Frequency
Semi-Annually

Performance

YTD-9.02%
1 Year-12.79%
3 Year+13.41%
5 Year-3.79%
10 Year+9.70%

Asset Allocation

Stocks: 96.08%
Cash: 1.75%
Other: 2.17%
See how much of MSPRX you already own
Your funds unpacked, overlap, fees and score, free on screen. The full report is $25, once. Download sample.
X-ray my portfolio free

Top Holdings

View All →
TickerNameWeight
NETCloudflare Inc (180 Day Lockup)12.43%
TSLATesla Inc8.32%
SHOP:CAShopify Inc.7.53%
ABNBAirbnb Inc5.55%
RPRXRoyalty Pharma 3.55 09/02/20505.52%
Top 10 Concentration: 63.64%Report Date: Dec 31, 2025
Download all 33 holdings for MSPRX
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Frequency
Semi-Annually
Latest Distribution
$7.78
-

Peer Comparison

Benchmark
PRO
Peer outperformance: PRO
Category rank: PRO
This Mutual Fund
PRO
Peer Avg
PRO

MSPRX Mutual Fund Overview

MSPRX Mutual Fund (Morgan Stanley Institutional Fund Advantage Portfolio Class C) is managed by Morgan Stanley Investment Management. MSPRX expense ratio is 1.95%, holding 33 positions across sectors including Information Technology, Consumer Discretionary, Financials. Inception date: 2015-04-30.

MSPRX performance shows a YTD return of -9.02%. The 1-year return is -12.79% and the 5-year return is -3.79%.

MSPRX top holdings include Cloudflare Inc (180 Day Lockup) (12.4%), Tesla Inc (8.3%), Shopify Inc. (7.5%), Airbnb Inc (5.5%), Royalty Pharma 3.55 09/02/2050 (5.5%). Go to all MSPRX holdings, MSPRX sectors, or MSPRX dividends.

MSPRX can be compared against other funds. Use MSPRX overlap to find shared positions, or MSPRX vs another fund for a side-by-side view. MSPRX alternatives are available via the screener, along with tax-loss harvesting opportunities.